{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6214f04174d82e00145af407/69d613c3086c93c18b8c4008?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"From risk to rights: rethinking type 1 diabetes screening ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6214f04174d82e00145af407/1775637409871-0a407063-bed9-4d0b-9bdc-babcf8d204dd.jpeg?height=200","description":"<p>In this episode, host Dr Phylissa Deroze is joined by Dr Michael Haller, Chief of Pediatric Endocrinology at the University of Florida, and diabetes advocate Ricardo de Oliveira to explore type 1 diabetes screening as both a medical breakthrough and a political issue. They share how early detection can prevent life-threatening diagnosis experiences, reduce complications, and reshape care. The conversation addresses policy gaps, health equity and why screening must become a standard, accessible part of diabetes care worldwide.</p>","author_name":"International Diabetes Federation"}